$VICR

VINCIARELLI PATRIZIO sold $6.1M of VICR

VINCIARELLI PATRIZIO (Chairman & CEO) sold 20,000 shares of VICOR CORP (VICR) at an average of $304.87 ($296.12–$309.20, $6.10M total) across 13 trades on 2026-06-12 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · VINCIARELLI PATRIZIO
Published Jun 16, 2026, 5:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 16, 2026, 5:37 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$VICR
Neutral
medium confidence
Mentioned
$VICR
Relevance
5/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$VICRNeutralLow
01

Why it matters

The newest concrete information is the disclosed open-market sale size (~$6.1M) and the confirmation that it was executed under a pre-arranged Rule 10b5-1 plan.

02

Market read

This is a routine insider-sale disclosure; it may slightly affect sentiment but is unlikely to change valuation without additional company-specific catalysts.

03

What to watch

Traders may overreact to insider sales; the key nuance here is the 10b5-1 pre-arrangement and the fact the trades occurred days before filing.

Relevance 5/10Novelty 6/10Timing: Filed 2026-06-16; sale executed 2026-06-12.

Background

SEC Form 4 reports an insider transaction by VINCIARELLI PATRIZIO (Chairman & CEO, 10% owner) for VICOR CORP.

Company-level read

Ticker impact

$VICRNeutralMedium confidence
Context

VICR’s CEO/Chairman sold about $6.1M of VICR shares in an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low probability of a sustained price move solely from this filing; any reaction is likely short-lived.

Evidence & confidence

The filing is a routine insider sale (S code) with stated 10b5-1 plan, reducing interpretive weight versus discretionary selling.

Market effects

No sector-wide implication; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, the disclosure may have minimal informational content and may not warrant a directional trade.

Key entities

  • VICOR CORP

    Company whose shares were sold by its Chairman & CEO via Form 4.

  • VINCIARELLI PATRIZIO

    Chairman & CEO and 10% owner who executed the sale under a 10b5-1 plan.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ: